Mark Emalfarb
Founder bei DYADIC INTERNATIONAL, INC.
Vermögen: 8 Mio $ am 31.03.2024
Aktive Positionen von Mark Emalfarb
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DYADIC INTERNATIONAL, INC. | Director/Board Member | 01.01.2004 | - |
| Chief Executive Officer | 01.06.2008 | - | |
| Founder | 01.01.1979 | - | |
| President | 01.06.2008 | - | |
| Chairman | 01.06.2008 | 01.01.2015 | |
Dyadic International (USA), Inc.
 Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Chief Executive Officer | 05.10.2011 | - |
| Chairman | 05.10.2011 | - | |
Biotechnology Development for Industry in Pharmaceuticals SLU
 Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Director/Board Member | 13.09.2017 | - |
Karriereverlauf von Mark Emalfarb
Ausbildung von Mark Emalfarb
| University of Iowa | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Spanien | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Chairman | 2 |
Sektoral
| Health Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DYADIC INTERNATIONAL, INC. | Health Services |
| Private Unternehmen | 2 |
|---|---|
Dyadic International (USA), Inc.
Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Health Technology |
Biotechnology Development for Industry in Pharmaceuticals SLU
Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Commercial Services |
- Börse
- Insiders
- Mark Emalfarb
- Erfahrung
